Skip to content

MaxCyte MXCT Asset turnover

Asset turnover at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
0.3×0.0×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.4×0.0×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
0.1×0.0×
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
0.5×+0.2×
PDE
Pro-Dex, Inc.PDEX
1.1×0.0×
Repligen logo
RepligenRGEN
0.2×0.0×

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

Based on trailing twelve months.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's asset turnover?
MaxCyte (MXCT) reported asset turnover of 0.2× in Q1 2026.
How has MaxCyte's asset turnover changed year-over-year?
MaxCyte's asset turnover decreased by 1.5% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for MaxCyte's asset turnover?
Over 4 years (2021 to 2025), MaxCyte's asset turnover has grown at a -7.2% compound annual growth rate (CAGR), from 0.2× to 0.1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.